H.-T. Wu

机构：Natera (United States)

发表论文 4 篇 · 总被引 509 次 · h-index 4

代表论文

• Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival (2020 · Annals of Oncology · 被引 463)
• Association of post-operative ctDNA detection with outcomes of patients with early breast cancers (2024 · ESMO Open · 被引 30)
• Presence of circulating tumour DNA in surgically resected renal cell carcinoma is associated with advanced disease and poor patient prognosis (2019 · Annals of Oncology · 被引 11)
• Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single agent pembrolizumab (P) (2019 · Annals of Oncology · 被引 5)